{"id":45046,"date":"2022-06-14T13:01:50","date_gmt":"2022-06-14T11:01:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/"},"modified":"2022-06-14T13:01:50","modified_gmt":"2022-06-14T11:01:50","slug":"world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/","title":{"rendered":"World Innovation Lab Raises $1 Billion to Bridge the Innovation Gap Across the Global Venture Ecosystem"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\nInflux of capital will fuel WiL Ventures III fund, WiL Strategic Partners funds and Corporate Venture Capital funds; WiL\u2019s capital commitments now exceed $1.9 billion\n<\/li>\n<li>\nWiL\u2019s mission: bridge the innovation gap between Japan, the US and the rest of the world\n<\/li>\n<li>\nWiL\u2019s investment thesis: provide growth investment capital for innovators across the spectrum of digital transformation, health tech, sustainability, Web3, and emerging technologies\n<\/li>\n<\/ul>\n<p>PALO ALTO, Calif. &amp; TOKYO&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/B2BSaaS?src=hash\" target=\"_blank\" rel=\"noopener\">#B2BSaaS<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwilab.com%2F&amp;esheet=52748855&amp;newsitemid=20220614005426&amp;lan=en-US&amp;anchor=World+Innovation+Lab&amp;index=1&amp;md5=c15af828a593c40a555ae6195b717c46\" rel=\"nofollow noopener\" shape=\"rect\">World Innovation Lab<\/a> (WiL) today announced the venture capital firm has raised over $1 billion in additional capital. The capital will be deployed across multiple funds including WiL\u2019s third growth fund, WiL Ventures III; WiL\u2019s venture fund investments, WiL Strategic Partners funds; and corporate VC (CVC) funds. Capital commitments across all funds now exceed $1.9 billion.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220614005426\/en\/1485538\/5\/US-JP-Team-WiL.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220614005426\/en\/1485538\/21\/US-JP-Team-WiL.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20220614005426\/en\/1485535\/5\/WIL-vertical-RGB-trans.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220614005426\/en\/1485535\/21\/WIL-vertical-RGB-trans.jpg\"><\/a><\/p>\n<p>\nWith offices in Palo Alto, California, and Tokyo, WiL\u2019s mission is to strengthen the global venture ecosystem by bridging startups and corporates in the United States and Asia, with a particular focus on Japan \u2014 Asia\u2019s leader in SaaS adoption, as well as the world\u2019s second largest enterprise software market and third largest consumer market.\n<\/p>\n<p>\nWiL partners with its broad limited-partner base of leading Japanese corporations and government entities to enable U.S. and European startups to scale in Japan, and supports the innovation and globalization of Japanese companies.\n<\/p>\n<p>\nThe firm\u2019s portfolio boasts a total of 15 unicorns to date. Notable WiL investments that have exited to public markets from Fund I and Fund II include Asana, Mercari, Raksul, Wise and Auth0 \u2014 whose acquisition by Okta was completed in May 2021.\n<\/p>\n<p>\n\u201cWe thank our LPs for fueling WiL\u2019s ongoing growth and empowering us to invest in the next generation of disruptive companies,\u201d<b> <\/b>said Gen Isayama, WiL co-founder and CEO. \u201cRight from the start, our mission has been to create a mutually beneficial relationship for our LPs and founders. So far, we have predominantly invested in the B2B SaaS space. Those solutions can be used by our entire LP base. This enables our founders to easily attract their lighthouse customers in the Japan market, while at the same time helping our LPs with their digital transformation efforts. We aim to strengthen this partnership between our LPs and founders.\u201d\n<\/p>\n<p>\n<b>Bridging Startups &amp; Corporates \u2014 a Cross-Cultural Approach to Venture Investment<\/b>\n<\/p>\n<p>\nWiL\u2019s investment thesis has evolved across its funds. But the one constant is addressing LPs\u2019 pain points. WiL\u2019s first two funds have emphasized investment in digital transformation, with its U.S. investments generally concentrated on later-stage rounds, such as Series B and beyond in the B2B SaaS space. Target sectors have included fintech, insurtech, automation and productivity, cybersecurity, cloud infrastructure and developer tools. The firm also invests in the same sectors in Japan, but capital also is deployed to early-stage companies.\n<\/p>\n<p>\nIn addition to direct investments, WiL invests in established and emerging venture capital funds through its WiL Strategic Partners funds. To further help its LPs achieve their innovation and growth objectives, WiL has developed a track record of developing creative investment structures with its LP partners, including the creation of spinout companies and joint ventures.\n<\/p>\n<p>\nWiL Ventures III adds sustainability, climate tech, health tech, Web3, and other emerging technologies as new areas of investment. The firm\u2019s continued goal is to identify solutions that are most relevant to the business and societal challenges its corporate and government LP base is looking to solve. Collaborating with LPs and operating corporate VC funds will also be a new area of focus.\n<\/p>\n<p>\nJust as it has adopted creative investment structures, WiL has developed a unique organizational structure to support entrepreneurs and LPs in different geographies and across different cultures. On top of its U.S. and Japan Investment teams, WiL has also established Empowerment &amp; Corporate Innovation and Platform teams to maximize synergies between startups and corporates.\n<\/p>\n<p>\nBy providing its LPs with a wide menu of services aimed at empowering innovation and growth within their enterprises \u2014 such as design-thinking workshops, hosting of expats in WiL\u2019s Silicon Valley office and establishment of joint ventures and spin-offs \u2014 WiL\u2019s Empowerment &amp; Corporate Innovation team helps its LPs accelerate their own digital transformation and become more ready to partner with technology startups. This becomes mutually beneficial to WiL\u2019s portfolio companies pursuing expansion into Japan and Asian markets and partnerships with enterprises.\n<\/p>\n<p>\nThe Platform team also collaborates with all WiL teams to help portfolio companies optimize growth in the areas of hiring, business development and go-to-market strategy. The team also supports various aspects in CVC operations.\n<\/p>\n<p>\nWiL believes that its cross-cultural approach and strong set of company values are what enables the firm to deliver on its promises to founders and LPs.\n<\/p>\n<p>\n<b>About World Innovation Lab<\/b>\n<\/p>\n<p>\nFounded in 2014, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwilab.com%2F&amp;esheet=52748855&amp;newsitemid=20220614005426&amp;lan=en-US&amp;anchor=World+Innovation+Lab&amp;index=2&amp;md5=e2f616782fe1717a9048885d28b28774\" rel=\"nofollow noopener\" shape=\"rect\">World Innovation Lab<\/a> (WiL) is a venture capital firm that partners with leading global corporations and government entities in Japan and Asia. With offices in Palo Alto, California, and Tokyo, the firm\u2019s mission is to serve as a bridge between startups and corporations in the United States and Asia, with a particular focus on Japan. WiL supports its portfolio companies by establishing corporate partnerships that enable U.S. and European startups to scale globally, and Japanese startups to innovate and globalize. WiL invests in emerging technology spanning fintech, insurtech, automation and productivity, cybersecurity, cloud infrastructure, developer tools, health tech and sustainability. Notable WiL investments that have exited to public markets from Fund I and Fund II include Asana, Mercari, Raksul, Wise and Auth0 \u2014 whose acquisition by Okta was completed in May 2021. WiL also invests in exceptional venture funds, and supports its LPs in corporate venture investment efforts. For more, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwilab.com%2F&amp;esheet=52748855&amp;newsitemid=20220614005426&amp;lan=en-US&amp;anchor=wilab.com.&amp;index=3&amp;md5=47748ca2e62e26f4f28af8b75438105f\" rel=\"nofollow noopener\" shape=\"rect\">wilab.com.<\/a>\n<\/p>\n<p>\n<i>This press release is not an offer to sell securities and is not soliciting an offer to buy securities in any jurisdiction where the offer or sale is not permitted. All statements, other than statements of historical fact, included herein are &#8220;forward-looking statements.&#8221; The forward-looking statements are based on WiL<\/i><i>\u2019s beliefs, assumptions and expectations of its future performance, taking into account information currently available. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to WiL or are within its control.<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nEthan Parker<br \/>\n<br \/><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftreblepr.com%2F&amp;esheet=52748855&amp;newsitemid=20220614005426&amp;lan=en-US&amp;anchor=Treble&amp;index=4&amp;md5=ce0d83c67f11326fd8fc4d024b174766\" rel=\"nofollow noopener\" shape=\"rect\">Treble<\/a><br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x77;&#105;&#x6c;&#64;&#x74;&#114;&#x65;&#98;&#x6c;&#101;&#x70;&#114;&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">wi&#108;&#64;&#116;&#114;&#x65;&#x62;&#x6c;&#x65;&#x70;r&#46;&#99;&#111;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Influx of capital will fuel WiL Ventures III fund, WiL Strategic Partners funds and Corporate Venture Capital funds; WiL\u2019s capital commitments now exceed $1.9 billion WiL\u2019s mission: bridge the innovation gap between Japan, the US and the rest of the world WiL\u2019s investment thesis: provide growth investment capital for innovators across the spectrum of digital &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45046","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>World Innovation Lab Raises $1 Billion to Bridge the Innovation Gap Across the Global Venture Ecosystem - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"World Innovation Lab Raises $1 Billion to Bridge the Innovation Gap Across the Global Venture Ecosystem - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Influx of capital will fuel WiL Ventures III fund, WiL Strategic Partners funds and Corporate Venture Capital funds; WiL\u2019s capital commitments now exceed $1.9 billion WiL\u2019s mission: bridge the innovation gap between Japan, the US and the rest of the world WiL\u2019s investment thesis: provide growth investment capital for innovators across the spectrum of digital ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-14T11:01:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220614005426\/en\/1485538\/21\/US-JP-Team-WiL.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"World Innovation Lab Raises $1 Billion to Bridge the Innovation Gap Across the Global Venture Ecosystem\",\"datePublished\":\"2022-06-14T11:01:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\\\/\"},\"wordCount\":1056,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614005426\\\/en\\\/1485538\\\/21\\\/US-JP-Team-WiL.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\\\/\",\"name\":\"World Innovation Lab Raises $1 Billion to Bridge the Innovation Gap Across the Global Venture Ecosystem - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614005426\\\/en\\\/1485538\\\/21\\\/US-JP-Team-WiL.jpg\",\"datePublished\":\"2022-06-14T11:01:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614005426\\\/en\\\/1485538\\\/21\\\/US-JP-Team-WiL.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220614005426\\\/en\\\/1485538\\\/21\\\/US-JP-Team-WiL.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"World Innovation Lab Raises $1 Billion to Bridge the Innovation Gap Across the Global Venture Ecosystem\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"World Innovation Lab Raises $1 Billion to Bridge the Innovation Gap Across the Global Venture Ecosystem - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/","og_locale":"en_US","og_type":"article","og_title":"World Innovation Lab Raises $1 Billion to Bridge the Innovation Gap Across the Global Venture Ecosystem - Pharma Trend","og_description":"Influx of capital will fuel WiL Ventures III fund, WiL Strategic Partners funds and Corporate Venture Capital funds; WiL\u2019s capital commitments now exceed $1.9 billion WiL\u2019s mission: bridge the innovation gap between Japan, the US and the rest of the world WiL\u2019s investment thesis: provide growth investment capital for innovators across the spectrum of digital ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-14T11:01:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220614005426\/en\/1485538\/21\/US-JP-Team-WiL.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"World Innovation Lab Raises $1 Billion to Bridge the Innovation Gap Across the Global Venture Ecosystem","datePublished":"2022-06-14T11:01:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/"},"wordCount":1056,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220614005426\/en\/1485538\/21\/US-JP-Team-WiL.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/","url":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/","name":"World Innovation Lab Raises $1 Billion to Bridge the Innovation Gap Across the Global Venture Ecosystem - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220614005426\/en\/1485538\/21\/US-JP-Team-WiL.jpg","datePublished":"2022-06-14T11:01:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220614005426\/en\/1485538\/21\/US-JP-Team-WiL.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220614005426\/en\/1485538\/21\/US-JP-Team-WiL.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/world-innovation-lab-raises-1-billion-to-bridge-the-innovation-gap-across-the-global-venture-ecosystem\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"World Innovation Lab Raises $1 Billion to Bridge the Innovation Gap Across the Global Venture Ecosystem"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45046"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45046\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}